| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 9, 860-865, Copyright © 1995 by The Federation of American Societies for Experimental Biology
REVIEWS |
DC Altieri
Boyer Center for Molecular Medicine, Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06536, USA.
Cellular inflammatory responses and early mechanisms of vascular injury are invariably associated with activation of blood coagulation and deposition of insoluble fibrin. This process occurs on vascular cell surfaces through the ability of the coagulation protease factor Xa to generate thrombin. However, experimental evidence accumulated during the past decade underscores how prothrombin activation is only one of the biological consequences of factor Xa assembly on vascular cells. Instead, binding of factor Xa to leukocytes, endothelium, and smooth muscle cells triggers complex pathways of intracellular signal transduction that participate, directly or indirectly, in the regulation of cellular growth. One of the cellular binding sites for factor Xa, designated effector cell protease receptor-1 (EPR-1), has recently emerged as a novel potential regulator of factor Xa-mediated mitogenic signaling. For its activation-dependent phenotype on leukocyte subsets, its ability to costimulate lymphocyte proliferation through release of intracellular second messengers, and its regulated cellular expression by alternative mRNA splicing, EPR-1 may influence vascular cell growth and aberrantly contribute to the earliest pathogenetic processes of vascular diseases.
This article has been cited by other articles:
|
|
 |
|
  O Sanchez-Pernaute, J Esparza-Gordillo, R Largo, E Calvo, M A Alvarez-Soria, M E Marcos, G Herrero-Beaumont, and S R de Cordoba Expression of the peptide C4b-binding protein {beta} in the arthritic joint Ann Rheum Dis, October 1, 2006; 65(10): 1279 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kojima, M. Iida, Y. Yaguchi, R. Suzuki, N. Hayashi, H. Moriyama, and Y. Manome Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene. Arch Otolaryngol Head Neck Surg, June 1, 2006; 132(6): 682 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pennati, M. Binda, M. De Cesare, G. Pratesi, M. Folini, L. Citti, M. G. Daidone, F. Zunino, and N. Zaffaroni Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo Carcinogenesis, July 1, 2004; 25(7): 1129 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Grandaliano, P. Pontrelli, G. Cerullo, R. Monno, E. Ranieri, M. Ursi, A. Loverre, L. Gesualdo, and F. P. Schena Protease-Activated Receptor-2 Expression in IgA Nephropathy: A Potential Role in the Pathogenesis of Interstitial Fibrosis J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2072 - 2083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Bryant Biology and Pathogenesis of Thrombosis and Procoagulant Activity in Invasive Infections Caused by Group A Streptococci and Clostridium perfringens Clin. Microbiol. Rev., July 1, 2003; 16(3): 451 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Sanchez-Pernaute, M. J. Lopez-Armada, E. Calvo, I. Diez-Ortego, R. Largo, J. Egido, and G. Herrero-Beaumont Fibrin generated in the synovial fluid activates intimal cells from their apical surface: a sequential morphological study in antigen-induced arthritis Rheumatology, January 1, 2003; 42(1): 19 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Camerer, H. Kataoka, M. Kahn, K. Lease, and S. R. Coughlin Genetic Evidence That Protease-activated Receptors Mediate Factor Xa Signaling in Endothelial Cells J. Biol. Chem., May 3, 2002; 277(18): 16081 - 16087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-L. Hung, E. S. Pollak, R. D. Kudaravalli, V. Arruda, K. Chu, and K. A. High Regulation of human coagulation factor X gene expression by GATA-4 and the Sp family of transcription factors Blood, February 15, 2001; 97(4): 946 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Konno, H. Yamakawa, H. Utsunomiya, K. Ito, S. Sato, and A. Yajima Expression of survivin and Bcl-2 in the normal human endometrium Mol. Hum. Reprod., June 1, 2000; 6(6): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Conway, S. Pollefeyt, J. Cornelissen, I. DeBaere, M. Steiner-Mosonyi, K. Ong, M. Baens, D. Collen, and A. C. Schuh Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions Blood, February 15, 2000; 95(4): 1435 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ambrosini, C. Adida, G. Sirugo, and D. C. Altieri Induction of Apoptosis and Inhibition of Cell Proliferation by survivin Gene Targeting J. Biol. Chem., May 1, 1998; 273(18): 11177 - 11182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Papapetropoulos, P. Piccardoni, G. Cirino, M. Bucci, R. Sorrentino, C. Cicala, K. Johnson, V. Zachariou, W. C. Sessa, and D. C. Altieri Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling PNAS, April 14, 1998; 95(8): 4738 - 4742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Rothermel and D. C. Altieri High affinity cross-reacting mAb generated by minimal mimicry: Implications for the pathogenesis of anti-nuclear autoantibodies and immunosuppression PNAS, March 31, 1998; 95(7): 3816 - 3820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Carmeliet and D. Collen Molecular analysis of blood vessel formation and disease Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2091 - H2104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ambrosini, J. Plescia, K. C. Chu, K. A. High, and D. C. Altieri Activation-dependent Exposure of the Inter-EGF Sequence Leu83-Leu88 in Factor Xa Mediates Ligand Binding to Effector Cell Protease Receptor-1 J. Biol. Chem., March 28, 1997; 272(13): 8340 - 8345. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
